BONE LOSS AND TURNOVER AFTER CARDIAC TRANSPLANTATION

Citation
E. Shane et al., BONE LOSS AND TURNOVER AFTER CARDIAC TRANSPLANTATION, The Journal of clinical endocrinology and metabolism, 82(5), 1997, pp. 1497-1506
Citations number
44
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
0021972X
Volume
82
Issue
5
Year of publication
1997
Pages
1497 - 1506
Database
ISI
SICI code
0021-972X(1997)82:5<1497:BLATAC>2.0.ZU;2-#
Abstract
Cardiac transplantation is associated with increased prevalence and in cidence of fracture, and rapid bone loss has been reported during the first posttransplant year. To define further the pattern and etiology of bone loss after cardiac transplantation, we enrolled 70 patients (5 2 men and 18 women) in a prospective 3-yr study. Bone densitometry (BM D) and biochemical indexes of mineral metabolism were performed before and at defined times after transplantation. Despite supplementation w ith elemental calcium (1000 mg/day) and vitamin D (400 IU/day), the me an rate of bone loss during the first year was 7.3 +/- 0.9% (+/-SEM) a t the lumbar spine and 10.5 +/- 1.1% at the femoral neck. The rate of bone loss slowed (P < 0.001 compared to year I) at both sites (0.9 +/- 0.9% and 0.1 +/- 1.0%, respectively) during the second year. During t he third year, lumbar spine BMD increased at a rate of 2.4 +/- 0.8%/yr (P < 0.02 compared to year 2), but femoral neck BMD did not change. A t the radius, the rate of decline in BMD was negligible during the fir st year (0.9 +/- 0.5%), but was significant during the second (2.1 +/- 0.6%; P < 0.01) and third (2.9 +/- 0.8%; P < 0.03) years. Evaluation of the pattern of bone loss during the first year demonstrated that me an lumbar spine BMD decreased rapidly during the first 6 months, after which there was no further decline. In contrast, femoral neck BRID co ntinued to fall at an annualized rate of 8.2 +/- 1.3% during the secon d half of the year. The pattern and rates of bone loss were similar in men and women. Biochemistries revealed decreases in serum testosteron e and osteocalcin and increases in all bone resorption markers 1 and 3 months after transplantation, with a return to baseline by 6 months. Higher rates of bone loss were associated with greater exposure to pre dnisone, lower serum concentrations of vitamin D metabolites, greater suppression of osteocalcin, higher levels of bone resorption markers, and, in men, lower serum testosterone concentrations. We conclude that rapid bone loss is primarily confined to the initial year after trans plantation. During the first 6 months, bone loss is accompanied by alt erations in markers of bone turnover consistent with biochemical uncou pling of bone formation and resorption. Greater exposure to glucocorti coids, lower serum concentrations of vitamin D metabolites and testost erone, and higher bone turnover were associated with more rapid bone l oss.